Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $10.2650 (-6.13%) ($10.2650 - $10.2650) on Mon. Nov. 21, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.05% (three month average) | RSI | 38 | Latest Price | $10.2650(-6.13%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -4.6% a day on average for past five trading days. | Weekly Trend | EDIT declines -2.3% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(58%) IWC(53%) IWO(50%) IWM(49%) IWN(47%) | Factors Impacting EDIT price | EDIT will decline at least -2.525% in a week (0% probabilities). VIXM(-13%) VXX(-8%) XLU(-3%) XBI(-3%) UUP(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.525% (StdDev 5.05%) | Hourly BBV | -1.2 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-2.3(-122.41%) | Resistance Level | $11.92 | 5 Day Moving Average | $11.47(-10.51%) | 10 Day Moving Average | $11.78(-12.86%) | 20 Day Moving Average | $11.92(-13.88%) | To recent high | -36.7% | To recent low | 0% | Market Cap | $637m | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |